• Oluwaseyi Sedowhe Ashaka, Olumuyiwa Babalola Salu, Ayorinde Babatunde James, Akeeb Oriowo Bola Oyefolu, AbdulAzeez Adeyemi Anjorin, Bamidele Oludare Oke, Mercy Remilekun Orenolu, and Sunday Aremu Omilabu.
• Medical Microbiology and Parasitology, College of Health Sciences, University of Ilorin, Ilorin, Nigeria.
• Afr Health Sci. 2020 Mar 1; 20 (1): 219226219-226.

BackgroundParvovirus B19 (B19) has tropism for cells of the erythroid lineage, which may lead to transient inhibition of erythropoiesis. Several studies and case reports suggested that B19 infection may contribute significantly to severe chronic anemia in HIV infected persons.ObjectiveTo detect parvovirus B19 DNA in treatment-naïve HIV patients.MethodsThis was a case control retrospective study. One hundred nineteen anemic and 81 non-anemic treatment-naïve HIV infected patients participated in the study at the Lagos University Teaching Hospital, Lagos, Nigeria. Polymerase chain reaction was used to detect B19 DNA.ResultsOut of 200 patients analysed, 13(6.5%) had parvovirus B19 DNA. Eight HIV patients with anemia had B19 DNA while five non-anemic HIV patients had B19 DNA. This suggests that the presence of B19 DNA in the blood of HIV positive individuals may contribute to anemia because the majority (61.5%) who were positive for B19 DNA had anemia as compared to the non-anemic control group (38.5%).ConclusionThis study shows that the presence of B19 DNA in anemic HIV infected patients is not associated with chronic anaemia in HIV infection because no significant association exist.© 2020 Ashaka OS et al.

46 keywords...

hide…